Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China
This article was originally published in PharmAsia News
You may also be interested in...
China’s MOH-SFDA Merger: Analysts Weigh In
SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing
Medical Insurance Plan Expected To Boost Size Of China Pharma Market
SHANGHAI - China's basic medical insurance program will cover all urban residents in the country by the end of this year, the State Council of China announced recently
Sidley Austin Beijing Senior Counsel Chen Yang: An Interview with PharmAsia News
Chen Yang, senior counsel in Sidley Austin's Beijing office, recently spoke with PharmAsia News about recent developments in China that affect the pharmaceutical and medical device industries. Yang leads the firm's China life sciences practice. For the past 10 years, she has advised international companies on their investment projects and acquisition efforts in various Chinese industries and provided regulatory advice on intellectual property, life science, employment and other issues. She has also assisted China government agencies in several U.S. litigation matters.